LataMed AI Evaluates Integration of Installment-Based Healthcare Payments via Cashea Platform
LataMed AI Corp. is assessing the integration of Cashea's buy-now-pay-later service to reduce upfront healthcare costs and boost patient access in Latin America.
LataMed AI Corp. (OTC: LMED), a digital health and artificial intelligence company focused on emerging markets, announced today that it has initiated an evaluation process to potentially integrate installment-based healthcare payment capabilities through Cashea, a leading buy-now-pay-later platform in Venezuela. The initiative aims to reduce upfront financial barriers for patients seeking private healthcare services, including consultations, diagnostics, wellness programs, and other offerings within the LataMed AI ecosystem.
Management believes that improving payment accessibility could drive greater patient engagement, increase healthcare utilization, and strengthen platform adoption. By addressing affordability challenges, the company hopes to solidify its position as a technology-enabled healthcare marketplace serving patients, providers, and partners across Latin America. The potential integration aligns with LataMed AI’s broader strategy of combining artificial intelligence, telehealth infrastructure, care coordination tools, and digital payment accessibility to build a scalable healthcare marketplace.
Dr. Kevin Rodan Levy, CEO of LataMed AI Corp., stated: “We believe financial accessibility is a critical component of healthcare delivery. Our objective is to evaluate solutions that may help patients obtain timely medical care while simultaneously expanding the reach and utility of our healthcare ecosystem. We believe initiatives such as this have the potential to strengthen patient acquisition, improve engagement, and support long-term platform growth.”
The company has not yet entered into a definitive commercial agreement, and completion of any integration remains subject to further commercial discussions, technical implementation requirements, regulatory review, and customary business conditions. LataMed AI intends to provide additional updates as material developments occur. For further information, visit https://latamed.ai or review the company’s filings with the U.S. Securities and Exchange Commission at www.sec.gov.
LataMed AI Corp. is a development-stage digital health and AI technology company focused on building telehealth infrastructure, healthcare coordination tools, analytics capabilities, and AI-enabled solutions for emerging markets, with an initial regional focus on Latin America. The company’s strategy centers on developing platforms that support healthcare access, patient engagement, provider coordination, emergency medical response, pharmacy integration, and data-driven operations.